These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1724365)
21. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery. Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394 [TBL] [Abstract][Full Text] [Related]
22. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
23. [Use of high doses of aprotinin in cardiac surgery]. Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058 [TBL] [Abstract][Full Text] [Related]
24. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
25. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009 [TBL] [Abstract][Full Text] [Related]
26. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction. Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654 [TBL] [Abstract][Full Text] [Related]
27. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363 [TBL] [Abstract][Full Text] [Related]
29. Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery. Stewart A; Newman L; Sneddon K; Harris M Br J Oral Maxillofac Surg; 2001 Oct; 39(5):365-70. PubMed ID: 11601817 [TBL] [Abstract][Full Text] [Related]
30. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414 [TBL] [Abstract][Full Text] [Related]
31. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
33. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin]. Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511 [TBL] [Abstract][Full Text] [Related]
34. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty]. Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474 [TBL] [Abstract][Full Text] [Related]
35. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial. Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691 [TBL] [Abstract][Full Text] [Related]
36. The efficacy of aprotinin in arterial switch operations in infants. Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883 [TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. Kikura M; Levy JH; Tanaka KA; Ramsay JG J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545 [TBL] [Abstract][Full Text] [Related]
38. [Effects of low doses of aprotinin in heart surgery]. Blanco E; Blanco J; Bóveda S; Sierra J; Rubio J; Durán D; Alvarez J Rev Esp Anestesiol Reanim; 1994; 41(3):168-71. PubMed ID: 7520188 [TBL] [Abstract][Full Text] [Related]
39. [Effects of "low dose" aprotinin in open heart surgery and its plasma concentration]. Nakamura T; Shimamoto M; Yamazaki F; Fujita S; Yoshimura T; Ueno T; Oyanagi H; Shinozaki T Nihon Kyobu Geka Gakkai Zasshi; 1994 Feb; 42(2):188-93. PubMed ID: 7511150 [TBL] [Abstract][Full Text] [Related]
40. [Effect of aprotinin on blood loss reduction after extracorporeal circulation]. Ueyama K; Kawasuji M; Sakakibara N; Tedoriya T; Takahashi M; Watanabe Y Nihon Kyobu Geka Gakkai Zasshi; 1993 Oct; 41(10):2093-9. PubMed ID: 7693833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]